Conclusions

Hyaluronan possesses a combination of unique physical properties and biological functions that allow it to serve as an important starting material for the preparation of new biocompatible and biodegradable polymers. This review highlights the chemistries involved in the modification of hyaluronan, and the potential medical applications of these hyaluronan-based biomaterials. Important new products have already reached the marketplace, and the approval and introduction of an increasing number of medical devices and new drugs using hyaluronan-derived biomaterials can be anticiptated in the next decade.

References

1. Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001; 12:69-78.

2. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997; 242:27-33.

3. Band PA. In: Laurent TC, ed. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives. London: Portland Press, 1998:33-42.

4. Vercruysse KP, Prestwich GD. Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst 1998; 15:513-555.

5. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release 1998; 53:93-103.

6. Luo Y, Kirker KR, Prestwich GD. In: Atala A, Lanza R, eds. Methods of Tissue Engineering. San Diego: Academic Press, 2001:539-553.

7. Barbucci R, Magnani A, Baszkin A, da Costa ML, Bauser H, Hellwig G, Martuscelli E, Cimmino S. Physico-chemical surface characterization of hyaluronic acid derivatives as a new class biomaterials. J Biomater Sci Polym Ed 1993; 4:245-273.

8. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, Williams DF. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 1998; 19:2101-2127.

9. Luo Y, Prestwich GD. Hyaluronic acid-N-hydroxysuccinimide: a useful intermediate for bioconjugation. Bioconjug Chem 2001; 12:1085-1088.

10. Barbucci R, Rappuoli R, Borzacchiello A, Ambrosio L. Synthesis, chemical and rheological characterization of new hyaluronic-based hydrogels. J Biomater Sci Polym Ed 2000; 11:383-399.

11. Barbucci R, Lamponi S, Borzacchiello A, Ambrosio L, Fini M, Torricelli P, Giardino R. Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials 2002; 23:4503-4513.

12. Hermanson GT. Bioconjugate Chemistry. San Diego: Academic Press, 1996.

13. Kuo JW, Swann DA, Prestwich GD. Chemical modification of hyaluronic acid by carbodiimides. Bioconjug Chem 1991; 2:232 -241.

14. Kuo JW, Swann DA, Prestwich GD. US patent 5356883, 1994.

15. Akima K, Ito H, Iwata Y, Matsuo K, Watari N, Yanagi M, Hagi H, Oshima K, Yagita A, Atomi Y, Tatekawa I. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity. J Drug Target 1996; 4:1-6.

16. Cera C, Terbojevich M, Cosani A, Palumbo M. Anthracycline antibiotics supported on water-soluble polysaccharides: synthesis and physicochemical characterization. Int J Biol Macromol 1988; 10:66-74.

17. Sakurai K, Miyazaki T, Kodera Y, Nishimura H, Shingu M, Inada Y. Antiinflammatory activity of superoxide dismutase conjugated with sodium hyalur-onate. Glycoconjug J 1997; 14:723-728.

18. Park YD, Tirelli N, Hubbell JA. Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials 2003; 24:893-900.

19. Matsuda T, Magoshi T. Preparation of vinylated polysaccharides and photofabrication of tubular scaffolds as potential use in tissue engineering. Biomacro-molecules 2002; 3:942-950.

20. Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 1999; 47: 152-169.

21. Crescenzi V, Francescangeli A, Taglienti A, Capitani D, Mannina L. Synthesis and partial characterization of hydrogels obtained via glutaraldehyde crosslinked of acetylated chitosan and of hyaluronan derivatives. Biomacromolecules 2003; 4: 1045-1054.

22. Crescenzi V, Francescangeli A, Taglienti A. New gelatin-based hydrogels via enzymatic networking. Biomacromolecules 2002; 3:1384-1391.

23. Pouyani T, Harbison GS, Prestwich GD. Novel hydrogels of hyaluronic acid: synthesis, surface morphology and solid-state NMR. J Am Chem Soc 1994; 116: 7515-7522.

Pouyani T, Prestwich GD. US patent 5,616,568, 1997.

Vercruysse KP, Marecak DM, Marecek JF, Prestwich GD. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjug Chem 1997; 8:686-694.

Moriyama K, Ooya T, Yui N. Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation. J Control Release 1999; 59:77-86. Prestwich GD, Vercruysse KP. Therapeutic applications of hyaluronic acid and hyaluronan derivatives. Pharm Sci Technol Today 1998; 1:42-43. Prestwich GD, Luo Y, Ziebell MR, Vercruysse KP, Kirker KR, MacMaster JS. In: Abatangelo G, Weigel PH, eds. New Frontiers in Medical Sciences: Redefining Hyaluronan. Amsterdam: Elsevier, 2000:181-194.

Pouyani T, Prestwich GD. Functionalized derivatives of hyaluronan acid oligosaccharides: drug carriers and novel biomaterials. Bioconjug Chem 1994; 5:339-347. Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem 1999; 10:755-763. Luo Y, Ziebell M, Prestwich GD. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 2000; 1:208-218. Luo Y, Bernshaw NJ, Lu Z-R, Kopecek J, Prestwich GD. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan biocojugates. Pharm Res 2002; 19: 396-402.

Shu XZ, Liu Y, Luo Y, Robert MC, Prestwich GD. Disulfide crosslinked hyaluronan hydrogel. Biomacromolecules 2002; 3:1304-1311. Shu XZ, Liu Y, Palumbo FS, Prestwich GD. Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular materix for in vitro cell growth. Biomaterials 2003; 24:3825-3834.

Liu Y, Shu XZ, Gray SD, Prestwich GD. Disulfide-crosslinked hyaluronan-gelatin sponges: growth of fibrous tissue in vivo. J Biomed Mater Res 2004; 68A: 142-149.

Shu XZ, Liu Y, Palumbo SF, Luo Y, Prestwich GD. In-situ crosslinkable hyaluronan hydrogel for tissue engineering. Biomaterials 2004; 25:1139-1348. Shu XZ, Ghosh K, Liu Y, Palumbo FS, Luo Y, Clark RA, Prestwich GD. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res 2004; 68A:365-375. Barbucci R, Magnani A, Casolaro M, Marchettini N, Rossi C, Bosco M. Modification of hyaluronic acid by sulfate group insertion to obtain heparin-like molecule: part I: characterisation and behaviour in aqueous solution towards H+ and Cu2+ ions. Gaz Chim Ital 1995; 125:169-180.

Magnani A, Albanese A, Lamponi S, Barbucci R. Blood-interaction performance of different sulfated hyaluronic acids. Thromb Res 1996; 81:383-395. Abatangelo G, Barbucci R, Brun P, Lamponi S. Biocompatibility and enzymatic degradation studies on sulphated hyaluronic acid and derivatives. Biomaterials 1997; 18:1411-1415.

Favia P, Palumbo F, D'Agostino R, Lamponi S, Magnani A, Barbucci R. Immobilization of heparin and highly-sulfated hyaluronic acid onto plasma-treated polyethylene. Plasma Polym 1998; 3:77-96.

Chen GP, Ito Y, Imanishi Y, Magnani A, Lamponi S, Barbucci R. Photo-immobilization of sulfated hyaluronic acid for antithrombogenicity. Bioconjug Chem 1997; 8:730-734.

43. Barbucci R, Magnani A, Lamponi S, Pasqui D, Bryant S. The use of hyaluronan and its sulphated derivative patterned with micrometric scale on glass substrate in melanocyte cell behaviour. Biomaterials 2003; 24:915-926.

44. Magnani A, Barbucci R, Montanaro L, Arciola CR, Lamponi S. In vitro study of blood-containing properties and effect on bacterial adhesion of polymeric surface with immobilized heparin and sulfate hyaluronic acid. J Biomater Sci Polym Ed 2000; 11:801-815.

45. Barbucci R, Magnani A, Lamponi S, Rappuoli R, Consumi M. In: Abatangelo G, Weigel PH, eds. New Frontiers in Medical Sciences: Redefining Hyaluronan. Amsterdam: Elsevier, 2000:203-212.

46. Coradini D, Pellizzaro C, Miglierini G, Daidone MG, Perbellini A. Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line. Int J Cancer 1999; 81:411-416.

47. Smeds KA, Pfister-Serres A, Hatchell DL, Grinstaff MW. Synthesis of novel polysaccharide hydrogel. JMS—Pure Appl Chem A 1999; 36:981-989.

48. Laurent TC, Hellsing K, Gelotte B. Crosslinked gels of hyaluronic acid. Acta Chem Scand 1964; 18:374-375.

49. Balazs EA, Leshchiner A, Band P. US patent 4,713,448, 1987.

50. Balazs EA, Leshchiner A. US patent 4,582,865, 1986.

51. Inukai M, Jin Y, Yomota C, Yonese M. Preparation and characterization of hyaluronate-hydroxyethyl acrylate blend hydrogel for controlled release device. Chem Pharm Bull 2000; 48:850-854.

52. Jin Y, Yamanaka J, Sato S, Miyata I, Yomota C, Yonese M. Recyclable characteristics of hyaluronate-polydroxyethyl acrylate blend hydrogel for controlled releases. J Control Release 2001; 73:173-181.

53. Leach JB, Bivens KA, Patrick CW Jr. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003; 82: 578-589.

54. Axen R, Porath J, Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 1967; 214:1302-1304.

55. Huang-Lee LLH, Nimni ME. Crosslinked CNBr-activated hyaluronan-collagen matrices: effects on fibroblast contraction. Matrix Biol 1994; 14:147-157.

56. Liu LS, Thompson AY, Heidaran MA, Poser JW, Spiro RC. An osteoconductive collagen/hyaluronate matrix for bone regeneration. Biomaterials 1999; 20: 1097-1108.

57. Liu LS, Ng C-K, Thompson AY, Poser JW, Spiro RC. Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2). J Biomed Mater Res 2002; 62:128-135.

58. Asayama S, Nogawa M, Takei Y, Akaike T, Maruyama A. Synthesis of novel polyampholyte comb-type copolymers consisting of a poly(L-lysine) backbone and hyaluronic acid side chains for a DNA carrier. Bioconjug Chem 1998; 9:476-481.

59. Dahl LB, Laurent TC, Smedsrod B. Preparation of biological intact radioiodinated hyaluronan of high specific radioactivity: coupling of 125I-tyramine-cellobiose to amino groups after partial N-deacetylation. Anal Biochem 1988; 175:397-407.

60. Oerther S, Maurin A-C, Payan E, Hubert P, Lapicque F, Presle N, Dexheimer J, Netter P, Lapicque F. High interaction alginate-hyaluronate association for the preparation of efficient biomaterials. Biopolymers 2000; 54:273-281.

Ohya S, Nakayama Y, Matsuda T. Thermoresponsive artificial extracellular matrix for tissue engineering: hyaluronic acid bioconjugated with poly(N-isopropylacry-lamide) grafts. Biomacromolecules 2001; 2:856-863.

Benedetti L, Cortivo R, Berti T, Berti A, Pea F, Mazzo M, Moras M, Abatangelo G. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials 1993; 14:1154-1160. Zhong SP, Campoccia D, Doherty PJ, Williams RL, Benedetti L, William DF. Biodegradation of hyaluronic acid derivatives by hyaluronidase. Biomaterials 1994; 15:359-365.

Brun P, Abatangelo G, Radice M, Zacchi V, Guidolin D, Daga Gordini D, Cortivo R. Chondrocyte aggregation and reorganization into three-dimensional scaffolds. J Biomed Mater Res 1999; 46:337-346.

Benedetti LM, Topp EM, Stella VJ. Microspheres of hyaluronic acid esters-fabrication methods and in vitro hydrocortisone release. J Control Release 1990; 13:33 - 41.

Benedetti LM, Joshi HN, Goei L, Hunt JA, Callegaro L, Stella VJ, Topp EM. Dosage forms from polymeric prodrugs: hydrocortisone esters of hyaluronic acid. New Polym Mater 1991; 3:41-48.

Drobnik J. Hyaluronan in drug delivery. Adv Drug Deliv Rev 1991; 7: 295-308.

Hume LR, Lee HK, Benedetti LM, Sanzgiri YD, Topp EM, Stella VJ. Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films. Int J Pharm 1994; 111:295-298.

Kyyronen K, Hume L, Benedetti LM, Urtti A, Topp E, Stella V. Methyl-prednisolone esters of hyaluronic acid in opthalmic drug delivery. Int J Pharm 1992; 80:161-169.

Nightlinger NS, Benedetti L, Soranzo C, Pettit DK, Pankey SC, Gombotz WR. In vitro release of huGM-CSF from esterified hyaluronic acid microspheres. Proc Int Symp Control Release Bioact Mater 1995; 22:738-739.

Ilium L, Farraj NF, Fisher AN, Gill I, Miglietta M, Benedetti LM. Hyaluronic acid ester microspheres as nasal delivery system for insulin. J Control Release 1994; 29:133-141.

Richardson JL, Ramire PA, Miglietta MR, Rochira M, Bacelle L, Callegaro L, Benedetti LM. Novel vaginal delivery systems for calcitonin 1. Evaluation of HYAFF calcitonin microspheres in rats. Int J Pharm 1995; 115:9-15. Bonucci E, Ballanti P, Ramires PA, Richardson JL, Bacelle L. Prevention of ovariectomy osteopenia to rats after vaginal administration of HYAFF 11 microspheres containing calcitonin. Calcif Tissue Int 1995; 56:274-279. Singh M, Briones M, O'Hagan DT. In: Abatangelo G, Weigel PH, eds. New Frontiers in Medical Sciences: Redefining Hyaluronan. Amsterdam: Elsevier, 2000:163-170.

Rooney P, Kumar S. Inverse relationship between hyaluronan and collagens in development and angiogenesis. Differentiation (Berlin) 1993; 54:1-9. Wheatley SC, Isacke CM, Crossley PH. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development (Cambridge, UK) 1993; 119: 295-306.

77. Peterson PE, Pow CST, Wilson DB, Hendrickx AG. Distribution of extracellular matrix components during early embryonic development in the macaque. Acta Anat 1993; 146:3-13.

78. Shepard S, Becker H, Hartmann JX. Using hyaluronic acid to create a fetal-like environment in vitro. Ann Plast Surg 1996; 36:65-69.

79. Cortivo R, DeGalateo A, Castellani I, Burn P, Giro MG, Abatangelo G. Hyaluronic acid promotes chick embyro fibroblast and chondroblast expression. Cell Biol Int Rep 1990; 14:111-122.

80. Chen W, Abatangelo G. The functions of hyaluronan in wound repair. Wound Repair Regen 1999; 7:79-89.

81. Chen WYJ. In: Kennedy JF, Phillips GO, Williams PA, eds. Hyaluronan Volume 2 Biomedical, Medical and Clinical Aspects. Cambridge, UK: Woodhead Publishing, 2002:147-156.

82. Pianigiani E, Andreassi A, Taddeucci P, Alessandrini C, Fimiani M, Andreassi L. A new model for studying differentiation and growth of epidermal cultures on hyaluronan-based carrier. Biomaterials 1999; 20:1689-1694.

83. Burn P, Cortivo R, Zavan B, Vecchiato N, Abatangelo G. In vitro reconstructed tissues on hyaluronan-based temporary scaffolding. J Mater Sci Mater Med 1999; 10:683-688.

84. Andreassi L, Casini L, Trabucchi E, Diamantini S, Rastrelli A, Donati L. Human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid suitable for grafting. Wounds 1991; 3:116-126.

85. Zacchi V, Soranzo C, Cortivo R, Radice M, Burn P, Abatangelo G. In vitro engineering of human skin-like tissue. J Biomed Mater Res 1998; 40:187-194.

86. Caravaggi C, Faglia E, Paola LD, Giglio RD, Caviani P, Mantero M, Gino M, Quarantiello A, Sommariva E, Pritelli C. In: Abatangelo G, Weigel PH, eds. New Frontiers in Medical Sciences: Redefining Hyaluronan. Amsterdam: Elsevier, 2000:313-320.

87. Harris PA, Francesco F, Barisono D, Leigh IM, Navsaria HA. Use of hyaluronic acid and cultured autologous keratinocytes and fibroblasts in extensive burns. Lancet 1999; 353:35-36.

88. Galassi G, Brun P, Radice M, Cortivo R, Zanon GF, Genovese P, Abatangelo G. In vitro reconstructed dernis implanted in human wounds: degradation studies of the HA-based supporting scaffold. Biomaterials 2000; 21:2183-2191.

89. Caravaggi C, Faglia E, Paola LD, Clerici G, Giglio RD, Sommariva E, Pritelli C, Manuela M, Caminiti M, Curci V, Fratino P In: Kennedy JF, Phillips GO, Williams PA, Hascall VC, eds. Hyaluronan Volume 2 Biomedical, Medical and Clinical Aspects. Cambridge, UK: Woodhead Publishing, 2002:79-86.

90. Tonello C, Zavan B, Cortivo R, Brun P, Panfilo S, Abatangelo G. In vitro reconstruction of human dermal equivalent enriched with endothelial cells. Biomaterials 2003; 24:1205 -1211.

91. Catapano G, Bartolo LD, Vico V, Ambrosio L. Morphology and metabolism of hepatocytes cultured in Petri dishes on films and in non-woven fabrics of hyaluronan acid esters. Biomaterials 2001; 22:629-665.

92. von Heimburg D, Zachariah S, Low A, Pallua N. Influence of different biodegradable carriers on the in vivo behavior of human adipose precursor cells. Plast Reconstr Surg 2001; 108:411-420.

Halbleib M, Skurk T, de Luca C, von Heimburg D, Hauner H. Tissue engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in vitro differentiation of human adipocyte precursor cells on scaffolds. Biomaterials 2003; 24:3125-3132.

Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Kastenbauer CHE, Naumann A. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res 1998; 42:172-181.

Huang L, Cheng YY, Koo PL, Lee KM, Qin L, Cheng JCY, Kumta SM. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. J Biomed Mater Res 2003; 66A:880-884. Awad HA, Erickson GR, Guilak F. In: Lewandrowski K-U, Wise DL, Trantolo DJ, Gresser JD, Yaszemski MJ, Altobelli DE, eds. Tissue Engineering and Biodegradable Equivalents: Scientific and Clinical Application. New York: Marcel Dekker, 2002:267-299.

Grigolo B, Lisignoli G, Piacentini A, Fiorini M, Gobbi P, Mazzotti G, Duca M, Pavesio A, Facchini A. Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAFF11): molecular, immunohistochemical and ultrastructural analysis. Biomaterials 2002; 23: 1187-1195.

Girotto D, Urbani S, Brun P, Renier D, Barbucci R, Abatangelo G. Tissue-specific gene expression in chondrocytes grown on three-dimensional hyaluronic acid scaffolds. Biomaterials 2003; 24:3265-3275.

Solchaga LA, Dennis JE, Goldberg VM, Caplan AI. Hyaluronic acid-based polymers as cell carriers for tissue-engineering repair of bone and cartilage. J Orthop Res 1999; 17:205-213.

Radice M, Burn P, Cortivo R, Scapinelli R, Battaliard C, Abatangelo G. Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res 2000; 50:101-109. Lisignoli G, Zini N, Remiddi G, Piacentini A, Puggioli A, Trimarchi C, Fini M, Maraldi NM, Facchini A. Basic fibroblast growth factor enhances in vitro mineralization of rat bone marrow stromal cells grown on non-woven hyaluronic acid based polymer scaffold. Biomaterials 2001; 22:2095-2105. Lisignoli G, Fini M, Giavaresi G, Aldini NN, Toneguzzi S, Facchini A. Osteogensis of large segmental radius defects enhanced by basic fibroblast growth factor activated bone marrow stromal cells grown on non-woven hyaluronic acid-based polymer scaffold. Biomaterials 2002; 23:1043-1051. Pelletier S, Hubert P, Payan P, Marchal P, Choplin L, Dellacherie E. Amphiphilic derivatives of sodium alginate and hyaluronate for cartilage repair: rheological properties. J Biomed Mater Res 2000; 54:102-108.

Johns DB, Rodgers KE, Donahue WD. Reduction of adhesion formation by postoperative administration of ionically crosslinked hyaluronic acid. Fertil Steril 1997; 68:37-42.

Lundorff P, Geldorp HV, Tronstad SE, Lalos O, Larsson B, Johns DD, diZerega GS. Reduction of post-surgical adhesions with ferric hyaluronate gel: a European study. Human Reprod 2001; 16:1982-1988.

Miyazaki T, Yomota C, Okada S. Development and release characterization of hyaluronan -doxycycline gels based on metal coordination. J Control Release 2001; 76:337-347.

107. Suh J-KF, Matthew HWT. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2000; 21:2589-2598.

108. Denuziere A, Ferrier D, Domard A. Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: physico-chemical aspects. Carbohydr Polym 1996; 29:317-323.

109. Denuziere A, Ferrier D, Damour O, Domard A. Chitosan-chondroitin sulfate and chtiosan-hyaluronate polyelectrolyte complexes: biological properties. Biomaterials 1998; 19:1275-1285.

110. Lim ST, Martin GP, Berry DJ, Brown MB. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release 2000; 66:281-292.

111. Picart C, Lavalle P, Cuisinier FJG, Schaaf P, Voegel JC. Buildup mechanism for poly(L-lysine)/hyaluronic acid films onto a solid surface. Langmuir 2001; 17: 7414-7424.

112. Picart C, Ladam G, Senger B, Voegel JC, Schaaf P, Cuisinier FJG, Gergely C. Determination of structural parameters characterizing thin films by optical methods: a comparison between scanning angle reflectometry and optical waveguide lightmode spectroscopy. J Chem Phys 2001; 115:1086-1094.

113. Picart C, Mutterer J, Richert L, Luo Y, Prestwich GD, Schaaf P, Voegel JC, Lavalle P. Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers. Proc Natl Acad Sci USA 2002; 99:12531-12535.

114. Schmidt CE, Shastri VR, Vacanti JP, Langer R. Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci USA 1997; 94: 8948-8953.

115. Garner B, Georgevich B, Hodgson AJ, Liu L, Wallace GG. Polypyrrole-heparin composites as stimulus-responsive substrates for endothelial cell growth. J Biomed Mater Res 1999; 44:121-129.

116. Collier JH, Camp JP, Hudson TW, Schmidt CE. Synthesis and characterization of polypyrrole-hyaluronic acid composite biomaterials for tissue engineering applications. J Biomed Mater Res 2000; 50:574-584.

117. Miralles G, Baudoin R, Dumas D, Baptiste D, Hubert P, Stoltz JF, Dellacherie E, Mainard D, Netter P, Payan E. Sodium alginate sponges with or without sodium hyaluronate: in vitro engineering of cartilage. J Biomed Mater Res 2001; 57: 268-278.

118. Lindenhayn K, Perka C, Spitzer R-S, Heilmann H-H, Pommerening K, Mennicke J, Sittinger M. Retention of hyaluronic acid in alginate beads: aspects for in vitro cartilage engineering. J Biomed Mater Res 1999; 44:149-155.

119. Larsen NE, Balazs EA. Drug delivery systems using hyaluronan and its derivatives. Adv Drug Deliv Rev 1991; 7:279-293.

120. Larsen NE, Pollak CT, Reiner K, Leshchiner E, Balazs EA. Hylan gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res 1993; 27: 1129-1134.

121. Piacquadio DJ. In: Elson ML, ed. Evaluation and Treatment of the Aging Face. New York: Springer, 1994:304-308.

122. Hallen L, Johansson C, Laurent C. Crosslinked hyaluronab (hylan B gel): a new injectable remedy for treatment of vocal fold insufficiency—an animal study. Acta Otolaryngol 1999; 119:107-111.

123. Larsen NE, Lombard KM, Parent EG, Balazs EA. Effects of hylan on cartilage and chondrocyte cultures. J Orthop Res 1992; 10:23-32.

Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 1997; 116:3-9.

Adams ME. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis. J Rheumatol 1993; 20:16-18. Kimmelman C, Edelstein C, Cheng H. Sepragel (hylan B) as a postsurgical dressing for endoscopic sinus surgery. Otolarynol Head Neck Surg 2002; 126:331 -332. Balazs EA, Eliezer-Pye IK, Dennebaum RA, Larsen NE, Whetstone JL. In: Kennedy JF, Phillips GO, Williams DF, Hascall VC, eds. Hyaluronan. Cambridge, UK: Woodhead Publishing, 2002; vol. 2:33-38.

Hu M, Sabelman EE, Tsai C, Tan J, Hentz VR. Improvement of schwann cell attachment and proliferation on modified hyaluronic acid strands by polylysine. Tissue Eng 2000; 6:585-593.

Ramamurthi A, Vesely I. Smooth muscle cell adhesion on crosslinked hyaluronan gels. J Biomed Mater Res 2002; 60:196-205.

Yui N, Nihira J, Okano T, Sakurai Y. Regulated release of drug microspheres from inflammation responsive degradable matrices of crosslinked hyaluronic acid. J Control Release 1993; 25:133-143.

Tomer R, Dimitrijevic D, Florence AT. Electrically controlled release of macromolecules from crosslinked hyaluronic acid hydrogel. J Control Release 1995; 33:405-413.

Tomihata K, Ikada Y. Preparation of crosslinked hyaluronic acid films of low water content. Biomaterials 1997; 18:189-195.

Glass JR, Dickerson KT, Stecker K, Polarek JW. Characterization of a hyaluronic acid Arg-Gly-Asp peptide cell attachment matrix. Biomaterials 1996; 17: 1101-1108.

Cooper ML, Hansbrough JF, Polarek JW. The effect of an arginine-glycine -

aspartic acid peptide and hyaluronate synthetic matrix on epithelialization of meshed skin graft interstices. J Burn Care Rehabil 1996; 17:108-116.

De Iaco PA, Stefanetti M, Pressato D, Piana S, Dona M, Pavesio A, Bovicelli L. A

novel hyaluronan-based gel in laparoscopic adhesion prevention: preclinical evaluation in an animal model. Fertil Steril 1998; 69:318-323.

De Iaco PA, Muzzupapa G, Pressato D, Bigon E, Rettore C, Dona M, Pavesio A,

Bovicelli L In: Abatangelo G, Weigel PH, eds. New Frontiers in Medical Sciences:

Redefining Hyaluronan. Amsterdam: Elsevier, 2000:345-349.

Solchaga LA, Gao J, Dennis JE, Awadallah A, Lundberg M, Caplan AI, Goldberg

VM. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 2002; 8:333-347.

Bernard GW, Pilloni A, Kang M, Sison J, Hunt D, Jovanovic S. In: Abatangelo G,

Weigel PH, eds. New Frontiers in Medical Sciences: Redefining Hyaluronan.

Amsterdam: Elsevier, 2000:215-231.

Solchaga LA, Goldberg VM, Caplan AI. In: Kennedy JF, Phillips GO, Williams DF, Hascall VC, eds. Hyaluronan. Cambridge, UK: Woodhead Publishing, 2002; vol. 2:63-66.

Tomihata K, Ikada Y. Crosslinking of hyaluronan acid with water-soluble carbodiimide. J Biomed Mater Res 1997; 37:243-251.

Jackson JK, Skinner KC, Burgess L, Sun T, Hunter WL, Burt HM. Paclitaxel-loaded crosslinked hyaluronan acid films for the prevention of postsurgical adhesions. Pharm Res 2002; 19:411-417.

142. Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release 2000; 69:169-184.

143. Kirker KR, Luo Y, Nielson JH, Shelby J, Prestwich GD. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 2002; 23:3661-3671.

144. Hu M, Sabelman EE, Lai S, Timek EK, Zhang F, Hentz VR, Lineaweaver WC. Polypeptide resurfacing method improves fibroblast's adhesion to hyaluronan strands. J Biomed Mater Res 1999; 47:79-84.

145. Ramire PA, E Milella. Biocompatibility of poly(vinyl alcohol)-hyaluronic acid and poly(vinyl alcohol)-gellan membranes crosslinked by glutaraldehyde vapors. J Mater Sci Meter Med 2002; 13:119-123.

146. Crescenzi V, Francescangeli A, Capitani D, Mannina L, Reiner D, Bellini D. Hyaluronan networking via Ugi's condensation using lysine as crosslinker diamine. Carbohydr Polym 2003; 53:311-316.

147. Yerushalmi N, Margalit R. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. Arch Biochem Biophys 1998; 349:21-26.

148. Yerushalmi N, Arad A, Margalit R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. Arch Biochem Biophys 1994; 313:267-273.

149. Peer D, Margalit R. Physicochemical evaluation of stability-driven approach to drug encapment in regular and in surface-modified liposomes. Arch Biochem Biophys 2000; 383:185-190.

150. Radomsky ML, Thompson AY, Spiro RC, Poser JW. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop Relat Res 1998; 355S:283-293.

151. Bowers D, Raybon B, Wheeless CR. Hyaluronic acid-carboxymethylcellulose films and perianastomotic adhesions in previously irradiated rats. Am J Obstet Gynecol 1999; 181:1335-1338.

152. Hooker GD, Taylor BM, Driman DK. Prevention of adhesion formation with use of sodium hyaluronate-based bioresorbable membrane in a rat model of ventral hernia repair with polypropylene mesh—a randomized, controlled study. Surgery 1999; 125:211-216.

153. Siebert JW, Burd AR, McCarthy JG, Weinzweig J, Ehrlich HP. Fetal wound healing: a biochemical study of scarless healing. Plast Reconstr Surg 1990; 85: 495-502.

154. Amiel D, Frey C, Woo SL, Harwood F, Akeson W. Value of hyaluronic acid in the prevention of contracture formation. Clin Orthop Relat Res 1985; 196:306-311.

155. Huang-Lee LLH, Nimni ME. Fibroblast contraction of collagen matrices with and without covalently bound hyaluronan. J Biomater Sci Polym Ed 1993; 5:99-109.

156. Park S-N, Park J-C, Kim HO, Song MJ, Suh H. Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopro-pyl)carbodiimide crosslinking. Biomaterials 2002; 23:1205-1212.

157. Park S-N, Lee HJ, Lee KH, Suh H. Biological characterization of EDC-crosslinked collagen-hyaluronic acid matrix in dermal tissue restoration. Biomaterials 2003; 24:1631-1641.

158. Iwata H. Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clin Orthop 1993; 289:285-291.

159. Wiebkin OW, Muir H. The inhibition of sulphate incorporation in isolated adult chondrocytes by hyaluronic acid. FEBS Lett 1973; 37:42-46.

160. Solursh M, Vaerewyck SA, Reiter S. Depression by hyaluronic acid of glycosaminoglycan synthesis by cultured chick embryo chondrocytes. Dev Biol 1974; 41:233-244.

161. Solursh M, Hardingham TE, Hascall VC, Kimura JH. Separated effects of exogenous hyaluronic acid on proteoglycan synthesis and deposition in pericellular matrix by cultured chick embryo limb chondrocytes. Dev Biol 1980; 75:121-129.

162. Larsen NE, Lombard KM, Balazs EA. Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 1991; 10:23-32.

163. Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, Shinmei M, Nakamura S, Kato Y. Effects of hyaluronic acid on the release of proteoglucan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993; 36:247-253.

164. Kawasaki K, Ochi M, Uchio Y, Adachi N, Matsusaki M. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cellular Physiol 1999; 179:142-148.

165. Bakos D, Soldan M, Hernandez-Fuentes I. Hydroxyapatite-collagen-hyaluronic acid composite. Biomaterials 1999; 20:191-195.

166. Rehakova M, Bakos D, Vizarova K, Soldan M, Jurickova M. Properties of collagen and hyaluronic composite materials and their modification by chemical crosslinking. J Biomed Mater Res 1996; 30:369-372.

167. Taguchi T, Ikoma T, Tanaka J. An improved method to prepare hyaluronic acid and type II collagen composite matrices. J Biomed Mater Res 2002; 61:330-336.

168. Angele P, Kujat R, Nerlich M, Yoo J, Goldberg V, Johnstone B. Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. Tissue Eng 1999; 5:545-553.

169. Choi YS, Hong SR, Lee YM, Song KW, Park MH, Nam YS. Studies on gelatin-containing artificial skin: II. Preparation and characterization of crosslinked gelatin-hyaluronate sponge. J Biomed Mater Res 1999; 48A:631-639.

Chemistry and Biology of Hyaluronan H.G. Garg and C.A. Hales (editors) © 2004 Elsevier Ltd. All rights reserved.

Natural Arthritis Relief

Natural Arthritis Relief

Natural Arthritis Relief details a unique method of reversing Rheumatoid Arthritis Symptoms by removing numerous arthritis triggers as well as toxins using a simple 5 step natural process.

Get My Free Ebook


Post a comment